WHY WE NEED YOU
55 Australians are diagnosed with breast cancer each and every day. Research is the only way we can improve treatment outcomes that will help stop deaths from breast cancer.
THIS IS WHAT WE ARE UP AGAINST
Breast cancer is still the most diagnosed cancer in Australia. Ageing population, health and lifestyle factors and better detection have all contributed to an increase in breast cancer diagnoses rates.
To improve breast cancer survival rates for those living with breast cancer, research is key. By taking part in the 55 Squat Challenge and and raising funds we can continue to fund novel and scientific research into new and improved treatments to ensure those living with breast can have the best possible outcome.
THE IMPACT OF COVID-19 ON BREAST CANCER DIAGNOSES
During the April 2020 lockdowns roughly 98 per cent of breast screens were cancelled or delayed across Australia. There were 20,000 fewer breast screening procedures than what would have been expected in a normal year.
As a result, it is estimated that there may have been between 10,000 and 20,000 cases of cancer that have been missed during the pandemic. With breast cancer being the most commonly diagnosed cancer in Australia, NBCF is concerned that many of these 10-20k cases are likely to be those who have undiagnosed breast cancer.
This could result in more advanced breast cancer diagnoses in the coming years.
That's why breast cancer research is more important than ever.
WHERE YOUR MONEY GOES
By completing the 55 Squat Challenge and raising funds for the National Breast Cancer Foundation (NBCF), you're supporting world-class breast cancer research - research that will help us detect tumours earlier, improve treatment outcomes and ultimately - save lives. The more we raise the more research we can fund. Meet some of our NBCF-funded researchers who are helping us work towards our goal of Zero Deaths from breast cancer by 2030.
Associate Professor Belinda Parker
University of Melbourne and Peter MacCallum Cancer Centre.
Project name: Predicting Breast Cancer Spread Using Novel Biomarkers.
"NBCF has supported the expansion of my research group and the ability to translate our basic research findings into the clinic. Without funding from NBCF, making the transition from bench to bedside would be delayed."
Click here to find out more about work of Associate Prodessor Belinda Parker.
